Sample Size Determination in Clinical Trials with an Emphasis on Exponentially Distributed Responses
From MaRDI portal
(Redirected from Publication:3201541)
Recommendations
- Sample size determination for grouped exponential observations: a cost function approach
- Fixed and sequential treatment allocation in clinical trials
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- Determination of the optimal sample size for a clinical trial accounting for the population size
- Nonparametric Estimation of Duration of Accrual and Total Study Length for Clinical Trials
Cited in
(8)- Sample size determination in clinical trials with multiple endpoints
- Most stable sample size determination in clinical trials
- SOME OBSERVATIONS ON THE MAKUCH/SIMON APPROACH TO SAMPLE SIZE DETERMINATION IN CLINICAL TRIALS WITH HISTORICAL CONTROLS
- Sample size calculations for noninferiority trials with Poisson distributed count data
- Sample size selection in clinical trials when population means are subject to a partial order: one-sided ordered alternatives
- Cost-efficient clinical studies with continuous time survival outcomes
- Determination of the optimal sample size for a clinical trial accounting for the population size
- Sample size determination for grouped exponential observations: a cost function approach
This page was built for publication: Sample Size Determination in Clinical Trials with an Emphasis on Exponentially Distributed Responses
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201541)
